| MICHAEL J. SHUSTER, Ph.D. |
 |
|
| Emphasis |
 |
|
Biotechnology Patent Prosecution |
|
|
Patent Litigation |
|
|
Strategic IP Counseling |
|
|
Portfolio Analysis and Due Diligence |
|
|
| Profile |
Dr. Shuster has legal and technical experience representing companies in biotechnology and high technology areas that include protein and nucleic acid chemistry, clean tech, high resolution protein structures, proteomics, genomics, combinatorial peptide libraries, vaccine development for viral and autoimmune disorders, transdermal drug delivery systems, liposomal drug formulations as well as microfluidics devices.
|
|
| Education |
University of San Francisco School of Law, J.D., cum laude, 1997 Columbia University, Ph.D., The Department of Physiology and Molecular Biophysics, 1986 Brandeis University, B.A., in biophysics, magna cum laude, 1981
|
|
| Admitted to Practice |
Member of the State Bar of California. |
|
| Additional Information |
Dr. Shuster received his undergraduate education at Brandeis University, graduating with a B.A. in Biophysics. He received his Ph.D. from Columbia University's Department of Physiology and Molecular Biophysics. While at Columbia he worked with Professor Eric Kandel as part of a team focused on discovery of mechanisms by which short term memories are stored, work for which Professor Kandel was awarded the Nobel Prize in Medicine in 2000. Dr. Shuster pursued his interests in ion channel biophysics and protein structure, first as a Markey post-doctoral fellow at UCSF's Department of Biochemistry & Biophysics, and then as a research biochemist studying neuronal mechanisms of pain transduction in UCSF's Department of Medicine.
Currently, Dr. Shuster is a co-instructor of "A Life Scientist's Guide to Intellectual Property" at UCSF, and regularly lectures about intellectual property law subjects. He is past chair of the Intellectual Property section of the Barrister's Club of San Francisco. In 2009, Dr. Shuster was listed as one of the Daily Journal's Top 25 Intellectual Property Portfolio Managers.
Dr. Shuster has published numerous scientific papers in peer-reviewed journals as well as articles on biotechnology patent law. Representative technologies for which he's written and prosecuted patent applications include genomics, proteomics, bioinformatics, vaccines, microfluidic devices, drug delivery methods and microarrays.
Organization and Community Participation
| | American Bar Association | | | California Bar Association | | | San Francisco Bar Association | | | San Francisco Intellectual Property Law Association | | | Biophysical Society |
Articles
Of Babies and Bathwater – The Impact of In Re Bilski on Life Science Patents, Michael Shuster & Juleen Konkel, 1 Hastings Science and Technology Law Journal 153, Summer 2009.
An Unclear Diagnosis, Michael Shuster & Juleen Konkel Daily Journal, June 2009.
Protecting Patents for Personalized Medicine, Michael Shuster & Pauline Farmer-Koppenol BioPharm International, September 2008.
Observations on Recent Developments in Patent Law: Is the Generic Claim Turning Into an Endangered Species?, Michael J. Shuster, Pauline Farmer-Koppenol and H. Thomas Anderson Jr. Burrill Report Personalized Medicine, November, 2007.
Planning for the other shoe to drop - Future echoes of LabCorp v. Metabolite, Michael J. Shuster and H. Thomas Anderson Jr. Burrill Report Personalized Medicine, November, 2006.
Responding to the Avian Flu Threat: Balancing Risks and Rewards, Michael J. Shuster, BioPharm International, February 1, 2006.
Managing Innovation: University-industry partnerships and the licensing of the Harvard mouse, Sasha Blaug, Colleen Chien and Michael J. Shuster Nature Biotechnology, Vol. 22, No. 6 (June 2004).
Altering Patent Suit Proof Burden Would Chill Innovation, Michael J. Shuster, Daniel Flamm and Sasha Blaug, Washington Legal Foundation, April 16, 2004.
Enzo Biochem v. Gen-Probe: Complying with the written description requirement under U.S. patent law, Nature Biotechnology, January, 2003.
Protecting Rights to Early-Stage Technology, Michael J. Shuster, Henry Su & Sasha Blaug, Nature Biotechnology, June, 2003.
Presentations
AAMA Speaker Series - Life Sciences, Asia America MultiTechnology Association, June 26, 2007.
Life Science Entrepreneurs' Forum, FountainBlue Consulting Services, September 18, 2006.
A Life Scientist's Guide to Intellectual Property: Drafting Patent Applications, UCSF, April 25, 2006.
A Life Scientist's Guide to Intellectual Property: Life and Death of a Patent, UCSF, April 18, 2006.
6th Advanced Forum on Biotech Patents: Constructing The Plan For The Future, American Conference Institute, February 16, 2006.
Radio Interview on World Talk Radio's Biotech Today, September 24, 2003. |
|
| Representative Clients |
|
|
Abbott Laboratories |
|
|
Alnylam Pharmaceuticals, Inc. |
|
|
BioCryst Pharmaceuticals, Inc. |
|
|
Climos, Inc. |
|
|
Crescendo Bioscience, Inc. |
|
|
Isis Pharmaceuticals, Inc. |
|
|
Joule Biotechnologies, Inc. |
|
|
Kleiner Perkins Caufield & Byers |
|
|
Mohr, Davidow Ventures |
|
|
Monogram Biosciences, Inc. |
|
|
The Regents of the University of California |
|
|
The University of Southern California |
|
|
|
 |
|
|
|
